Does Semaglutide Cause Erectile Dysfunction? What the Evidence Actually Shows

Erectile dysfunction is not listed as a recognised side effect of semaglutide in the UK prescribing information or NHS patient guidance.
Significant weight loss (which semaglutide can produce) is associated with improvements in testosterone levels and erectile function in men with obesity.
Temporary reductions in energy and libido can occur during the early weeks of treatment, often related to GI side effects rather than the medicine's direct action.
Any new or worsening sexual health concern while on semaglutide should be discussed with a prescriber — it may be unrelated to the medicine entirely.

Semaglutide is not known to cause erectile dysfunction directly. It does not appear in the medicine's list of recognised side effects, and the clinical trial data for Wegovy (semaglutide 2.4mg) did not identify ED as an adverse event linked to the drug itself. That said, the relationship between semaglutide, weight, hormones and sexual health is more layered than a simple yes or no — and if you're searching this question, you probably want the full picture, not a dismissal. These are prescription-only medicines; a prescriber assesses your suitability before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding semaglutide, erectile dysfunction and the evidence behind both

Why this question is worth taking seriously

The concern makes sense. You start a new medicine, something changes in how you feel, and you wonder whether the two are connected. That's a reasonable thing to question, and the honest answer is that the evidence, as it stands, does not point to semaglutide causing erectile dysfunction. The NHS patient guidance for semaglutide does not list ED among its side effects, and neither does the prescribing information used by clinicians in the UK.

What the trials do show is a medicine that produces substantial weight reduction. In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks. Across that participant group, ED was not identified as a drug-related adverse event. That's meaningful data, not absence of evidence.

The decision you're really weighing (whether semaglutide is right for you given this concern) is best made with a clear picture of what the medicine does and doesn't do to the body. The sections below work through that.

What semaglutide actually does to hormones and blood flow

Semaglutide works by activating GLP-1 receptors involved in appetite signalling and blood-sugar regulation, which is how it produces weight loss. It does not directly act on testosterone, oestrogen or the vascular pathways involved in erectile function.

Weight loss itself, however, does affect those pathways, and generally in the opposite direction to what many men fear. Obesity is associated with lower circulating testosterone, higher oestrogen conversion in fat tissue, and impaired blood flow: all of which contribute to erectile difficulties. Research consistently shows that meaningful weight reduction tends to improve testosterone levels and, with them, sexual function. So for men whose ED is connected to excess weight, semaglutide's primary effect (fat reduction) may over time prove beneficial rather than harmful.

The NHS medicines page for semaglutide covers the recognised side-effect profile in full. Fatigue and nausea feature prominently in the early weeks of treatment. Feeling consistently unwell or low in energy does affect libido and sexual confidence, but that's a consequence of GI adjustment, not a pharmacological action on sexual function, and it typically settles as the body adapts.

When something else might be going on

ED is common. Around 40% of men over 40 experience it at some point, and causes include cardiovascular disease, diabetes, stress, sleep disruption and certain other medicines, including some prescribed for blood pressure and depression. Starting a new weight-loss treatment is also a significant life change, and the psychological weight of that (self-consciousness, altered body image, relationship dynamics) can affect sexual function in ways that have nothing to do with the medicine.

If you're experiencing ED and you're on semaglutide or considering it, the important question is whether there's a plausible cause elsewhere. A prescriber can help map that, and our dedicated page on whether Wegovy can cause ED works through the evidence in detail. You can read more about other reported side effects of Wegovy to build a fuller picture of what the medicine does and doesn't do. Digestive effects (gas and bloating, for instance) are far better documented than any sexual health impact.

It's also worth knowing that semaglutide is a prescription-only medicine. No legitimate UK provider can supply it without a clinical assessment. That assessment is the right moment to raise concerns like this (openly, without embarrassment) so your prescriber can factor them into the decision.

Making the decision with the right information

If you're weighing up whether to start semaglutide and ED is your primary concern, the evidence doesn't support avoiding it on those grounds. If you're already taking it and have noticed a change, it's worth considering whether anything else has shifted (sleep, stress, other medicines, underlying health) before attributing it to the treatment.

A full overview of how semaglutide is used for weight management in the UK may help contextualise what treatment involves. For those exploring semaglutide in a medical spa or aesthetics setting, the medspa semaglutide page covers how that route works and what to expect. For those exploring semaglutide as a treatment option, the Wegovy treatment page covers the licensed indication, eligibility and how the clinical process works.

If you do want to speak to a prescriber directly (about this question or any other aspect of treatment) starting a free consultation with our clinical team is the straightforward next step. A named GPhC-registered prescriber reads every consultation; your questions are part of the clinical picture, not an inconvenience.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions